DAX19.790 -4,1%ESt504.656 -4,6%Top 10 Crypto10,92 -2,8%Dow37.878 -1,1%Nas15.579 -0,1%Bitcoin71.547 +0,5%Euro1,0941 -0,2%Öl64,66 -2,1%Gold2.960 -2,6%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 Tesla A1CX3T Allianz 840400 Amazon 906866 Apple 865985 Mercedes-Benz Group (ex Daimler) 710000 RENK RENK73 BASF BASF11 Lufthansa 823212 Infineon 623100 Deutsche Bank 514000 Volkswagen (VW) vz. 766403 Microsoft 870747 Berkshire Hathaway A0YJQ2
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Zollstreit: DAX beendet Handel nach Kursmassaker über Tagestief -- EU bietet USA Freihandelsdeal an -- Bitcoin fällt unter 80.000-Dollar-Marke -- QIAGEN, Goldpreis im Fokus
Top News
QIAGEN-Aktie dreht ins Plus: Gewinnprognose erhöht QIAGEN-Aktie dreht ins Plus: Gewinnprognose erhöht
Diese Aktien empfehlen Experten zu verkaufen Diese Aktien empfehlen Experten zu verkaufen
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
Wer­bung
Dividendensaison 2025: Welche Unternehmen überraschen positiv und welche enttäuschen? Das erwartet Anleger. Jetzt mehr erfahren!

Rogers Aktie

NeuKaufenVerkaufen
Rogers Aktien-Sparplan
55,50 EUR +0,50 EUR +0,91 %
FSE
61,65 USD +0,73 USD +1,20 %
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.1,02 Mrd. EUR

KGV72,41Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN863178

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS7751331015

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolROG

Rogers Aktien News

DatumMeistgelesen
PR NewswireRoche receives FDA clearance for additional Alzheimer's disease Cerebrospinal Fluid (CSF) assays, supporting timely diagnosis and treatment decision-making
PR NewswireRoche introduces navify® Sample Tracking for labs to track patient test samples before even reaching lab premises
PR NewswireRoche showcases commitment to advancing innovative diagnostic solutions at WorldLab-EuroMedLab
PR NewswireRoche showcases commitment to advancing innovative diagnostic solutions at WorldLab-EuroMedLab
PR NewswireRoche introduces navify® Algorithm Suite, a digital library of medical algorithms that enhances clinical decision-making to optimise patient care
PR NewswireRoche introduces navify® Algorithm Suite, a digital library of medical algorithms that enhances clinical decision-making to optimise patient care
PR NewswireRoche receives FDA approval of label expansion for VENTANA PD-L1 (SP263) Assay to identify patients with locally advanced and metastatic non-small cell lung cancer eligible for Libtayo
PR NewswireRoche joins forces with the U.S. Centers for Disease Control and Prevention to strengthen laboratory systems in the fight against the HIV and tuberculosis epidemics
PR NewswireRoche joins forces with the U.S. Centers for Disease Control and Prevention to strengthen laboratory systems in the fight against the HIV and tuberculosis epidemics
PR NewswireRoche joins forces with the U.S. Centers for Disease Control and Prevention to strengthen laboratory systems in the fight against the HIV and tuberculosis epidemics
PR NewswireRoche expands collaboration with Janssen to advance personalised healthcare through companion diagnostics
PR NewswireJana Care to Enter Collaboration with Roche to Develop and Distribute Blood Testing Platform to Improve Remote Care for Patients With Chronic Kidney and Heart Disease
PR NewswireNew Survey Shows Many Americans Are Confused by Testing Options for COVID-19 and Flu
PR NewswireRoche Announces Brad Moore as President and CEO of Roche Diagnostics North America
PR NewswireJnana Therapeutics Announces Second Collaboration with Roche to Address Challenging-to-Drug Targets in Cancer, Immune-Mediated and Neurological Diseases
PR NewswireRoche receives FDA approval for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first IHC-based companion diagnostic to identify ovarian cancer patients eligible for ELAHERE
PR NewswireRoche launches Pilot brand, expands retail channels for COVID-19 At-Home Test
PR NewswireRoche introduces the navify brand for its digital health solutions at HLTH 2022
PR NewswireRoche introduces the navify brand for its digital health solutions at HLTH 2022
PR NewswireRoche introduces the navify brand for its digital health solutions at HLTH 2022
PR NewswireRoche introduces the navify brand for its digital health solutions at HLTH 2022
PR NewswireRoche introduces the navify brand for its digital health solutions at HLTH 2022
PR NewswireRoche launches its next-generation SARS-CoV-2 Rapid Antibody Test
PR NewswireDuPont and Rogers Provide Update on Pending Merger
PR NewswireRoche's VENTANA PD-L1 (SP263) Assay receives CE IVD approval to identify patients with locally advanced and metastatic non-small cell lung cancer eligible for Libtayo
PR NewswireRoche's VENTANA PD-L1 (SP263) Assay receives CE IVD approval to identify patients with locally advanced and metastatic non-small cell lung cancer eligible for Libtayo
PR NewswireRoche's VENTANA PD-L1 (SP263) test gains CE label expansion as a companion diagnostic to identify non-small cell lung cancer patients eligible for Tecentriq
PR NewswireRoche's VENTANA PD-L1 (SP263) test gains CE label expansion as a companion diagnostic to identify non-small cell lung cancer patients eligible for Tecentriq
PR NewswireRoche launches COVID-19 test that detects and differentiates the emerging variant of interest BA.2.75
PR NewswireRoche launches COVID-19 test that detects and differentiates the emerging variant of interest BA.2.75
PR NewswireRoche receives FDA approval for VENTANA MMR RxDx Panel to identify dMMR solid tumour patients and pMMR endometrial cancer patients eligible for KEYTRUDA
Wer­bung

Rogers News

Rogers News: auf dieser Seite finden Sie alle Rogers News und Nachrichten zur Rogers Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Rogers News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Rogers News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.